Grace Therapeutics (GRCE) stock: insider trades, news & valuation
Health Care · Net buyingShare price and insider trades
Grace Therapeutics insider trading at a glance (Oct 9, 2026): in the past 12 months, 2 insiders bought $470K and 0 sold $0 of GRCE stock on the open market.
Get emailed when insiders cluster-buy stocks like GRCE
Free alerts the day a new cluster buy is filed, plus the Monday report of the week's biggest insider trades.
Free · unsubscribe anytime · not investment advice · see a sample issue
GRCE insider buying and selling by quarter
Open-market purchases (green, above the line) and sales (red, below), by trade date.
| Quarter | Bought | Purchases | Sold | Sales |
|---|---|---|---|---|
| Q4 2026 | $124K | 3 | — | 0 |
| Q3 2026 | $350K | 9 | — | 0 |
Valuation, profit and volume
Summary
Over the past 12 months, 2 Grace Therapeutics, Inc. insiders reported open-market purchases totaling $470K, while 0 insiders reported sales totaling $0. Among insiders with enough purchase history to measure, Opaleye Management Inc. (10% Owner) has the highest Insider Score at 99.
GRCE stock news and SEC filings
Recent 8-K filings and headlines. Tone is scored from the headline wording; “Policy” marks regulatory, trade or government topics.
Insider transactions
Open-market purchases and sales.
| Filed | Insider | Type | Shares | Price | Value | Since | Score |
|---|---|---|---|---|---|---|---|
| Oct 5SEC | Opaleye Management Inc.10% Owner | Buy | 38,7962,836,963 held (+1%) | $2.04 | $79K | +2.2% | 99 |
| Oct 5SEC | Opaleye Management Inc.10% Owner | Buy | 20,0002,856,963 held (+1%) | $2.07 | $41K | +0.6% | 99 |
| Oct 5SEC | Opaleye Management Inc.10% Owner | Buy | 1,6942,858,657 held (+0%) | $2.06 | $3K | +1.0% | 99 |
| Oct 1SEC | Opaleye Management Inc.10% Owner | Buy | 9,7712,785,000 held (+0%) | $2.10 | $21K | -1.0% | 99 |
| Oct 1SEC | Opaleye Management Inc.10% Owner | Buy | 7,8492,798,167 held (+0%) | $2.09 | $16K | -0.5% | 99 |
| Oct 1SEC | Opaleye Management Inc.10% Owner | Buy | 5,3182,790,318 held (+0%) | $2.10 | $11K | -1.0% | 99 |
| Sep 23SEC | Opaleye Management Inc.10% Owner | Buy | 9,7712,850,000 held (+0%) | $2.10 | $21K | -1.0% | 99 |
| Sep 23SEC | Opaleye Management Inc.10% Owner | Buy | 5,3182,855,318 held (+0%) | $2.10 | $11K | -1.0% | 99 |
| Sep 10SEC | Prashant KohliCEO | Buy | 100,000121,357 held (+468%) | $2.14 | $214K | -2.8% | — |
| Sep 10SEC | Opaleye Management Inc.10% Owner | Buy | 9,3932,769,393 held (+0%) | $2.10 | $20K | -1.0% | 99 |
| Sep 10SEC | Opaleye Management Inc.10% Owner | Buy | 5,8362,775,229 held (+0%) | $2.09 | $12K | -0.5% | 99 |
| Aug 19SEC | Opaleye Management Inc.10% Owner | Buy | 11,6082,760,000 held (+0%) | $2.09 | $24K | -0.5% | 99 |
Insiders at Grace Therapeutics, Inc.
| Insider | Bought | Sold | Last filing | Score |
|---|---|---|---|---|
| Opaleye Management Inc.10% Owner | $260K | — | Oct 5, 2026 | 99 |
| Prashant KohliCEO | $214K | — | Sep 10, 2026 | — |
Insider activity at other Health Care companies
Same sector, ranked by insider buying in the last 90 days.
GRCE stock: common questions
Are Grace Therapeutics, Inc. insiders buying GRCE stock?
In the past 12 months, 2 insiders reported open-market purchases of GRCE worth $470K. The latest was 10% Owner Opaleye Management Inc. bought $79K of GRCE at $2.04 — largest purchase by this insider in our records.
Are Grace Therapeutics, Inc. insiders selling GRCE stock?
0 insiders reported sales worth $0 over the same period.
Where does this data come from?
Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.
What is GRCE's 52-week range?
Over the past year GRCE has traded between $2.04 and $5.13. It last closed at $2.08 on Oct 9, 2026.